Որոնման արդյունքները - Hans‐Peter Brunner‐La Rocca
- Ցուցադրվում են 1 - 20 արդյունքները 91
- Գնացեք Հաջորդ էջ
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Comparative outcome one year after formal cardiac rehabilitation: the effects of a randomized intervention to improve exercise adherence Ines Arrigo, Hans‐Peter Brunner‐La Rocca, Michael Lefkovits, Matthias Pfisterer, Andreas Hoffmann
Հրապարակվել է 2008Artigo -
8
-
9
Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial Thilo Burkard, Christoph Kaiser, Hans‐Peter Brunner‐La Rocca, Stefan Osswald, Matthias Pfisterer, Raban Jeger
Հրապարակվել է 2011Artigo -
10
-
11
-
12
-
13
-
14
-
15
-
16
Reasons for readmission after hospital discharge in patients with chronic diseases—Information from an international dataset Hans‐Peter Brunner‐La Rocca, Carol J. Peden, John Soong, Per Arne Holman, Maria Bogdanovskaya, Lorna Barclay
Հրապարակվել է 2020Artigo -
17
-
18
-
19
Reoperative surgery for degenerated aortic bioprostheses: predictors for emergency surgery and reoperative mortality Peter Vogt, Hans‐Peter Brunner‐La Rocca, Patrick Sidler, Gregor Zünd, K. Truniger, Mário Lachat, J Turina, Marko Turina
Հրապարակվել է 2000Artigo -
20
Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction Sandra Sanders‐van Wijk, Vanessa van Empel, Nasser Davarzani, Micha T. Maeder, Rolf Handschin, Matthias Pfisterer, Hans‐Peter Brunner‐La Rocca
Հրապարակվել է 2015Artigo
Որոնման գործիքներ:
Առնչվող խորագիր
Medicine
Internal medicine
Cardiology
Heart failure
Ejection fraction
Myocardial infarction
Intensive care medicine
Natriuretic peptide
Pathology
Confidence interval
Randomized controlled trial
Endocrinology
Hazard ratio
Surgery
Cardiomyopathy
Blood pressure
Cohort
Diabetes mellitus
Environmental health
Guideline
Heart failure with preserved ejection fraction
Population
Atrial fibrillation
Chemistry
Clinical trial
Economics
Interquartile range
Nursing
Spironolactone
Biology